Axcelis Technologies, Inc. , a leading supplier of enabling ion implantation solutions for the semiconductor industry, today ...
LIBERTY is part of the Company’s broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated prophylaxis from COVID-19 and the potential medical benefits to ...
Zoonotic vaccines form an essential frontier in infectious disease prevention, bridging the gap between human and animal health. Zoonotic diseases, caused ...
OneMove Capital Ltd. ("OneMove"), an approximately 9.22% shareholder of Sylogist Ltd. ("Sylogist" or the "Company"), announced today that it has requisitioned a Special Meeting of Shareholders (the ...
On Amgen's call, the company's head of R&D, Jay Bradner, said the FDA's request for a voluntary withdrawal on 16th January ...
Ultragenyx Pharmaceutical (RARE) has put UX111, its gene therapy for Sanfilippo syndrome type A, back in the spotlight after releasing new long-term clinical data and resubmitting its Biologics ...
19hon MSN
Scientists use RNA nanotechnology to program living cells, opening a new path for cancer cure
Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...
The era of CureVac as an independent, publicly traded company has drawn to a close. This significant milestone follows the completion of its acquisition by riva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results